share_log

4: Statement of changes in beneficial ownership of securities-Officer Shanahan Karin

4: Statement of changes in beneficial ownership of securities-Officer Shanahan Karin

4:持股變動聲明-高管 Shanahan Karin
美股SEC公告 ·  11/05 17:56

Moomoo AI 已提取核心訊息

Bristol-Myers Squibb EVP Karin Shanahan has engaged in a transaction involving the company's common stock on 11/01/2024. The transaction involved direct shares with a par value of $0.10. Following the transaction, Shanahan holds a total of 5,336 direct shares in the company. Additionally, Shanahan has an indirect holding of 920.24 shares through the BMS Savings and Investment Program. The nature of the indirect shares indicates a vested interest in the company's performance through an employee benefit scheme. This transaction reflects the executive's ongoing investment in Bristol-Myers Squibb and provides investors with insight into executive stock ownership at the company.
Bristol-Myers Squibb EVP Karin Shanahan has engaged in a transaction involving the company's common stock on 11/01/2024. The transaction involved direct shares with a par value of $0.10. Following the transaction, Shanahan holds a total of 5,336 direct shares in the company. Additionally, Shanahan has an indirect holding of 920.24 shares through the BMS Savings and Investment Program. The nature of the indirect shares indicates a vested interest in the company's performance through an employee benefit scheme. This transaction reflects the executive's ongoing investment in Bristol-Myers Squibb and provides investors with insight into executive stock ownership at the company.
施貴寶執行副總裁Karin Shanahan在2024年11月1日參與了一筆涉及公司普通股的交易。該交易涉及直接股份,每股面值爲$0.10。在交易之後,Shanahan在公司持有5336股直接股份。此外,Shanahan通過bms系統儲蓄與投資計劃間接持有920.24股。間接股份的性質表明通過員工福利計劃對公司業績有着牢固的興趣。這筆交易反映了高管對施貴寶的持續投資,併爲投資者提供了有關公司高管持股情況的見解。
施貴寶執行副總裁Karin Shanahan在2024年11月1日參與了一筆涉及公司普通股的交易。該交易涉及直接股份,每股面值爲$0.10。在交易之後,Shanahan在公司持有5336股直接股份。此外,Shanahan通過bms系統儲蓄與投資計劃間接持有920.24股。間接股份的性質表明通過員工福利計劃對公司業績有着牢固的興趣。這筆交易反映了高管對施貴寶的持續投資,併爲投資者提供了有關公司高管持股情況的見解。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息